HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rapid tracheal infusion of surfactant versus bolus instillation in rabbits: effects on oxygenation, blood pressure and surfactant distribution.

AbstractUNLABELLED:
Surfactant bolus instillation may be associated with a drop in blood pressure. Platelet-activating factor (PAF) has been found in surfactant preparations. The aim of this study was to evaluate rapid tracheal infusion of surfactant during 5 min as an alternative to bolus instillation and to examine whether a PAF receptor antagonist is able to prevent the decrease in blood pressure.
METHODS:
Surfactant deficiency was induced in 16 adult rabbits by lung lavages with saline. Six animals received a bolus of a porcine surfactant preparation (Curosurf (CS); 200 mg/kg), labeled with red microspheres to assess pulmonary distribution. In another 5 rabbits, the same amount of labelled CS was instilled by tracheal infusion within 5 min. A third group of 5 animals received 3 mg/kg body weight of the PAF antagonist WEB 2170 before CS bolus instillation.
RESULTS:
After CS bolus administration, mean PaO2 increased by 44.7 +/- 8.3 kPa (mean +/- SD) within 2 min and remained at this level. Mean arterial blood pressure dropped transiently by 2.3 +/- 2 kPa within 5 min. Pulmonary distribution of surfactant was even. After infusion, mean PaO2 rose by 22.4 +/- 16.3 kPa within 15 min. Blood pressure dropped by 1.8 +/- 1.1 kPa within 15 min. The distribution was extremely uneven. Blood pressure decreases also occurred after pretreatment with PAF receptor antagonist.
CONCLUSION:
Rapid tracheal infusion of surfactant results in poorer oxygenation, an inhomogeneous distribution and a similar decrease in blood pressure compared to the bolus instillation method. Blood pressure changes could not be prevented by a PAF receptor-specific antagonist.
AuthorsH Segerer, A Scheid, M H Wagner, M Lekka, M Obladen
JournalBiology of the neonate (Biol Neonate) Vol. 69 Issue 2 Pg. 119-27 ( 1996) ISSN: 0006-3126 [Print] Switzerland
PMID8713657 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Azepines
  • Platelet Activating Factor
  • Platelet Aggregation Inhibitors
  • Surface-Active Agents
  • Triazoles
  • bepafant
  • Oxygen
Topics
  • Animals
  • Azepines (pharmacology)
  • Blood Pressure (drug effects)
  • Lung (metabolism)
  • Oxygen (blood)
  • Platelet Activating Factor (administration & dosage, metabolism, pharmacology)
  • Platelet Aggregation Inhibitors (pharmacology)
  • Rabbits
  • Surface-Active Agents (administration & dosage, pharmacology)
  • Tissue Distribution
  • Trachea
  • Triazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: